• Welcome Guest
  • View Cart
  • Phone (US): 703.778.3080
  • 0Shopping Cart
  • Market Reports
  • Market Research Subscriptions
    • Knowledge Center
  • Custom Market Research
    • Quantitative Market Research
    • Qualitative Market Research
    • Experts on Demand
    • RateMyProduct
  • Blog
  • Featured
    • Free Downloads
    • View Webinars On-Demand
    • The IVD Market in 2023: $130 Billion and Growing
    • The Point of Care Testing Market
    • Immunoassays
  • About Us
    • Contact
  • Search
  • Menu Menu
  • Biotechnology
    • Next Generation Sequencing
    • Proteomics
    • Biopharmaceuticals
    • Instrumentation & Equipment
    • Emerging Technologies
  • Pharmaceuticals
    • Vaccines
    • Drug Delivery
    • Over-the-Counter
    • Drug Discovery
    • Cancer Treatment
    • Manufacturing & Packaging
    • Prescription Drugs
  • Diagnostics
    • Molecular Assays
    • Point-of-Care
    • Immunoassays
    • Infectious Disease
    • Clinical Chemistry
    • Oncology & Hematology
    • Lab Testing Services
    • Medical Imaging
  • Healthcare
    • Information Technology
    • Facilities & Settings
    • Insurance & Managed Care
  • Medical Devices
    • Wound Care
    • Drug Delivery
    • Equipment
    • Surgical
  • Login
Sale!
Awaiting product image

Filter your search

Search Report Keyword
Price
CATEGORIES
  • Biotechnology Market Research
  • cell and gene therapy
  • cell therapy
  • Diagnostics Market Research
  • gene therapy
  • Healthcare Market Research
  • in vitro diagnostic
  • IVD
  • life sciences
  • Medical Devices Market Research
  • Molecular & Nucleic Acid Testing
  • Pharmaceuticals Market Research
  • Point-of-Care Diagnostics
  • sciences
  • vaccines

Knowledge Center Sidebar

Most Popular Research

  • Cell and Gene Therapy Business Outlook
  • The Worldwide Market for In Vitro Diagnostic Tests, 14th Edition
  • Clinical Diagnostics MasterFile
  • The Global Market for Medical Devices, 11th Edition
  • The World Market for Molecular Diagnostics Tests, 10th Edition
  • Remote Patient Monitoring and Telehealth Markets, 12th Edition

Brazil IVD Market Analysis

$2,800.00 – $5,600.00

Clear
SKU: KLI15386111 Categories: Clinical Chemistry, Diagnostics Market Research, Immunoassays Pages:
  • Description
  • Table of Contents
  • Latest reports

Description

Brazil IVD Market Analysis

Brazil IVD Market Analysis provides useful information to business planners including market size estimates for various segments, forecasts, competitive analysis, corporate profiles, market share and other information on the Brazilian laboratory market and its influences. The focus is on the IVD discipline including reagents, consumables, calibrators and controls of market segments, including:

  • Brazil IVD Sales by Market Segment, 2016-2021 (Clinical Chemistry, Immunoassay, Microbiology/Molecular, POC, Histology, Other, Total)
  • Brazil IVD Sales by Market Segment, 2016 Market Distribution (%) (Clinical Chemistry, Immunoassays, Microbiology/Molecular, POC, Histology, Other)
  • Brazil – Clinical Chemistry Revenues, 2016-2021
  • Brazil – Immunoassay Revenues Distribution, 2016-2021 (%) (Infectious Disease, Other, Total Immunoassay)
  • Brazil – Immunoassay Revenues by Segment, 2016 vs. 2021 (Infectious Disease, Other)
  • Brazil – Microbiology/Molecular Testing Revenues Distribution, 2016-2021 (%) (Infectious Disease, Other, Total Microbiology/Molecular Testing)
  • Brazil Microbiology/Molecular Testing Revenues by Segment, 2016 vs. 2021 (Infectious Disease, Other)
  • POC Revenues Distribution, 2016-2021 (%) (POC Glucose, POC Infectious Disease, POC Other, Total POC)
  • Brazil POC Revenues by Segment, 2016 vs. 2021 (POC Glucose, POC Infectious Disease, Others)
  • Brazil – Histology Revenues, 2016-2021

Brazil IVD Market Analysis notes trends influencing the opportunity and country-level information including incidence of disease, life expectancy, population demographics, economic status, healthcare utilization and other business influences.

The several global manufacturers that command Brazil’s IVD market, including Abbott Laboratories, Danaher Corporation, and Roche (F. Hoffman-La Roche, Ltd.), are profiled in the report. The information in Brazil IVD Market Analysis was gathered using both primary and secondary research methods, including more than 25 interviews completed during the period of April 2017 and June 2017.

Table of Contents

CHAPTER 1: EXECUTIVE SUMMARY

INDUSTRY OVERVIEW

SCOPE AND METHODOLOGY

BRAZIL IVD MARKET SUMMARY

Figure 1-1: Brazil In Vitro Diagnostic Sales by Market Segment, 2016-2021 (Clinical Chemistry, Immunoassay, Microbiology, POC, Histology, Other)

CHAPTER 2: BRAZIL OVERVIEW

POPULATION

Table 2-1: Total Midyear Population by Broad Age Group: Brazil (million persons), 2010-2050 (0-14, 15-64, 65+)

Figure 2-1: Total Midyear Population by Broad Age Group: Brazil (million persons), 2010-2050 (0-14, 15-64, 65+)

Figure 2-2: Total Number of Births in Brazil by Year, 1970-2010, and Forecast 2020-2050

Figure 2-3: Brazil Life Expectancy at Birth in Years, 2010-2050

Population Urbanization

ECONOMY AND HEALTH SPENDING

Figure 2-4: Brazil GDP, GDP (PPP) and Health Spending, 1990-2015

Figure 2-5: Brazil Distribution of Income or Consumption by Quintile, 1990-2014

CHAPTER 3: THE HEALTH SYSTEM IN BRAZIL

HEALTH INFRASTRUCTURE

Figure 3-1: Brazilian Coverage Rate (%) for Private Health Plans and Public Health Plans, 2003-2015 (Private Medical Aid Plan Beneficiaries with or without Dental Care, Public Health Plan Beneficiaries)

Figure 3-2: Health Expenditures, Public vs. Private as a % of Total Health Expenditures, 2015 (Private, Public)

Medical Facilities

Figure 3-3: Distribution of JCI Accredited Facilities by Metropolitan Area (%) (Sao Paulo, Rio de Janeiro, Recife, Brasilia, Porto Alegre, Others)

Figure 3-4: Distribution of JCI Accredited Facilities by Type (%) (Hospital Program, Academic Medical Center, Ambulatory Care, Home Care, Medical Transport, Primary Care)

Figure 3-5: Hospital Bed Density per 1,000 Population by Country, 2016 Estimates (US, UK, Singapore, Japan, Germany, China, Canada, Brazil, Australia)

Physicians and Health Professionals

Figure 3-6: Physician Density per 1,000 Population by Country, 2016 Estimates (US, UK, Singapore, Japan, Germany, China, Canada, Brazil, Australia)

Figure 3-7: Nurse/Midwife Density per 1,000 Population by Country, 2016 Estimates (US, UK, Singapore, Japan, Germany, China, Canada, Brazil, Australia)

The Brazilian Diagnostic Laboratory Environment

Figure 3-8: Laboratories and Collection Sites in Brazil by Type (%), 2016 (Collection Sites, all types; Commercial Laboratories; Hospital-based Laboratories)

Figure 3-9: Distribution of Volume, Brazil’s Leading Clinical Laboratory Service Providers (%), 2016

Medical Device Regulation

Table 3-1: Market Divers and Inhibitors for Entering Brazil’s Medical Device Market

Figure 3-10: Market Entry Complexity for Foreign Operators in Brazil

Brazil’s Growing Medical Tourism Industry

HEALTH INDICATORS

General Health

Disease Profiles in Brazil

Table 3-2: Top 5 Cancers Affecting Brazilian Population (ranked by total number of cases), 2010-2016 (Male, Female, Total [both sexes])

Figure 3-11: Highly Prevalent Medical Conditions/Diseases in Brazil (Zika virus, Tuberculosis, Malaria, Leprosy, HIV, Diabetes, Dengue, Chagas disease, Cardiovascular diseases, Cancer)

Surgical Procedures in Brazil

Table 3-3: Surgical Procedures in Brazil as Compared to Rest of Latin America (%) (Cardiovascular procedures, Digestive/Gastrointestinal procedures, Obstetrical/Gynecological procedures, Orthopedic procedures, ENT/Respiratory procedures, Urinary surgical procedures, Cosmetic/Aesthetic procedures, Other procedures, Total)

Figure 3-12: Brazil, Mexico and Rest of LATAM Distribution of Population Compared to Surgical Procedures (%)

CHAPTER 4: IVD MARKETS IN BRAZIL

BRAZIL IVD MARKET SUMMARY

Table 4-1: Brazil In Vitro Diagnostic Sales by Market Segment, 2016-2021 (Clinical Chemistry, Immunoassay, Microbiology/Molecular, POC, Histology, Other, Total)

Figure 4-1: Brazil In Vitro Diagnostic Sales by Market Segment, 2016-2021 (Clinical Chemistry, Immunoassay, Microbiology, POC, Histology, Other)

Figure 4-2: Brazil In Vitro Diagnostic Sales by Market Segment, 2016 Market Distribution (%) (Clinical Chemistry, Immunoassays, Microbiology/Molecular, POC, Histology, Other)

CLINICAL CHEMISTRY

Figure 4-3: Brazil – Clinical Chemistry Market, 2016-2021

IMMUNOASSAY

Table 4-2: Brazil – Immunoassay Market Distribution, 2016-2021 (%) (Infectious Disease, Other, Total Immunoassay)

Figure 4-4: Brazil – Immunoassay Market Value by Segment, 2016 vs. 2021 (Infectious Disease, Other)

MICROBIOLOGY/MOLECULAR

Table 4-3: Brazil – Microbiology/Molecular Testing Market Distribution, 2016-2021 (%) (Infectious Disease, Other, Total Microbiology/Molecular Testing)

Figure 4-5: Brazil Microbiology/Molecular Testing Market Value by Segment, 2016 vs. 2021 (Infectious Disease, Other)

POINT-OF-CARE

Table 4-4: Brazil – POC Market Distribution, 2016-2021 (%) (POC Glucose, POC Infectious Disease, POC Other, Total POC)

Figure 4-6: Brazil POC Market Value by Segment, 2016 vs. 2021 (POC Glucose, POC Infectious Disease, Others)

HISTOLOGY

Figure 4-7: Brazil – Histology Market, 2016-2021

CHAPTER 5: COMPETITIVE ANALYSIS AND PROFILES

COMPETITIVE SUMMARY

Table 5-1: Leading IVD Market Suppliers in Brazil, Market Share Percentage, 2016

Figure 5-1: Leading IVD Market Suppliers in Brazil, 2016 (%)

ABBOTT LABORATORIES

Table 5-2: Abbott Laboratories Company Summary

Company Overview

Company Performance

Product Summary

ALERE

Table 5-3: Alere Company Summary

Company Overview

Performance Review

Product Summary

BECTON, DICKINSON AND COMPANY

Table 5-4: Becton, Dickinson and Company Summary

Company Overview

Company Performance

Product Summary

BIOMÉRIEUX SA

Table 5-5: bioMerieux Summary

Company Overview

Company Performance

Product Summary

DANAHER CORPORATION

Table 5-6: Danaher Corporation Summary

Company Overview

Company Performance

Product Summary

ROCHE (F. HOFFMAN-LA ROCHE, LTD.)

Table 5-7: Roche Group Summary

Company Overview

Company Performance

Product Summary

SIEMENS HEALTHINEERS

Table 5-8: Siemens Healthineers Company Summary

Company Overview

Company Performance

Product Summary

SYSMEX CORPORATION

Table 5-9: Sysmex Corporation Summary

Company Overview

Company Performance

Product Summary

APPENDIX: SOURCES OF INFORMATION

 

    Clinical Laboratory Services Market, 8th Edition
    May 16, 2023
    Clinical Laboratory Services Market, 7th Edition
    June 28, 2022
    The World Market for Veterinary Diagnostics, 5th Edition
    February 23, 2022
    Clinical Laboratory Services Market, 6th Edition
    June 8, 2021

Related products

  • Placeholder image

    Molecular Diagnostics for Pharmacogenetic Testing: Testing volume, cost per test, and market potential

    $995.00 – $1,990.00
  • Placeholder image

    Diagnostics for Emerging Infectious Disease Threats Volume III: Bacterial Disease

    $1,995.00 – $3,990.00
  • Placeholder image

    Nucleic Acid-Based Therapeutics: World Markets, Developments, and Applications

    $3,500.00 – $7,000.00
  • Placeholder image

    Diagnostics for Emerging Infectious Disease Threats Volume I: Prion Disease

    $1,496.00 – $2,992.00

Contact Us

  •  Email Us: Customer Service

  •  Phone (US):  703-778-3080

  •  Fax:  703-778-3081

Pay Invoice

  • Pay an Invoice by Credit Card

Follow Us!

Latest Blogs

  • How Globalization and Climate Change Impact COVID-19 and the IVD Market September 20, 2023
  • IVD Trends 2023-2028: Emerging Growth Markets in Asia, Latin America, and the Middle East September 15, 2023
  • Worldwide IVD: 8 Key Trends to Watch in $106 Billion Market September 6, 2023
  • The Wide-Reaching Potential of Artificial Intelligence in Healthcare August 28, 2023
  • IVD for Pets: A $2.7 Billion Global Market July 24, 2023

Sitemap

  • Home
  • About
  • Blog
  • Contact
  • Sitemap

Your Data and Privacy

  • View our Privacy Policy
  • GDPR Statement

About Us

Kalorama Information, part of Science and Medicine Group, has been a leading publisher of market research in medical markets, including the biotechnology, diagnostics, medical device, and pharmaceutical industries for more than 30 years. Our comprehensive, timely, quality research and innovative approach to analysis and presentation of market intelligence have made Kalorama Information a premier source of market information for top industry decision makers.

Visit Science and Medicine Group
World Prescription Dermatological Drugs Market, 10th Edition (Antiacne &...Clinical Diagnostics PCR Markets by Type (Infectious Disease, Cancer, Cardiovascular,...
Scroll to top